As discussions continue around the hepatitis B vaccination schedule for newborns, a CDC advisory panel is set to vote on changes that could delay the vaccine, a move that has raised concerns among medical professionals and parents. The ongoing debate highlights the potential risks of postponing the birth dose of the hepatitis B vaccine, with experts warning that such changes could lead to increased infections and healthcare costs. Elements of the discussion include the opinions of vaccine advisory committees and influential figures like RFK Jr., whose panel is considering significant shifts in childhood vaccination policies. As the medical community watches closely, questions linger about the impacts of these proposed changes on public health and vaccination rates among children.